SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001401914-20-000028
Filing Date
2020-03-09
Accepted
2020-03-09 17:25:50
Documents
1
Period of Report
2020-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_158378913271078.html 3  
1 FORM 3 wf-form3_158378913271078.xml 3 4289
  Complete submission text file 0001401914-20-000028.txt   5893
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DARE BIOSCIENCE, INC. 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address
Fair John A (Reporting) CIK: 0001739140 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 20698984